NCT07647289
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Muscle-Invasive Bladder Cancer (MIBC), +3 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Muscle-Invasive Bladder Cancer (MIBC)
Explore clinical trials studying Muscle-Invasive Bladder Cancer (MIBC). Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Muscle-Invasive Bladder Cancer (MIBC) trial results
Not Yet Recruiting
Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma
NCT07639983
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer
NCT07624201
- Conditions
- Muscle-Invasive Bladder Cancer (MIBC)
- Locations
-
Not specified
Not Yet Recruiting
Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
NCT07529639
- Conditions
- Bladder Carcinoma, Carcinoma, Disease Attributes, +20 more
- Locations
-
Not specified